As per the research report, the size of the Latin America Cardiac Surgery Devices Market is valued at USD 0.25 billion in 2023 and estimated to be growing at a CAGR of 3.11%, reaching USD 0.29 billion by 2028 during the forecast period 2023 to 2028.
Increased use of surgical treatments in cardiology, expansion in the healthcare sector, and awareness campaigns drive the Latin American market. However, due to increased government and private sector investments in healthcare, rising purchasing power, and a high incidence of cardiac illnesses, the Latin American market is expected to develop at the fastest CAGR. Mexico, Brazil, and Argentina are two of the essential marketplaces.
Another critical driver driving this market is the rising prevalence of cardiovascular disorders, the increasing incidence of heart attacks and strokes, the increasing desire for minimally invasive procedures, and the rise in spending per capita income.
The cardiac surgery devices market is primarily driven by the rising frequency of heart disorders and the resulting increase in surgical procedures, the growing geriatric population, and increased government investments, funding, and grants.
Technologically upgraded equipment and an increase in government funding to develop better healthcare facilities and R&D are two significant factors driving the growth of the cardiac surgical devices market. Furthermore, rising healthcare expenditures and insurance premiums are likely to drive market growth during the forecast period.
Poor nutrition, stressed lives, obesity-related concerns, and other health problems prevalent in modern Latin America that eventually lead to heart illnesses are some reasons for the growth in the number of cardiac procedures.
The absence of experienced healthcare professionals and a lack of awareness among the general public and in some isolated areas limit expansion. In addition, the market for cardiac surgery is being held back by high investment costs and a scarcity of surgeons.
This research report on the Latin America Cardiac Surgery Devices Market has been segmented and sub-segmented into the following categories.
By Product Type:
By Application:
By Age Group:
By Country:
Geographically, Latin America accounts for a moderate share of the global market for cardiac surgery devices. On the other hand, essential factors driving regional expansion in this market include an increase in the pool of patients, increased government policies, and an increase in the number of surgical procedures.
The Mexico Cardiac Surgery Devices Market is expected to reach a significant growth because of the rise in diabetes, atherosclerosis, strokes, hypertension, and other chronic disorders during the forecast period.
The Brazil Cardiac Surgery Devices Market is predicted to rise rapidly due to the change in lifestyle habits like unhealthy dietary habits, lack of physical activity, and smoking that boost the regional growth of the market, leading to disorders of the circulatory system.
KEY MARKET PLAYERS
Prominent companies leading the Latin America Cardiac Surgery Devices Market profiled in the report are Trinity Biotech, Abiomed, Inc., Transmedics, Inc, C. R. Bard, Inc., MedWaves Incorporated, CyberHeart Incorporated, Cardinal Health.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region